Therapeutic uses of microencapsulated genetically engineered cells

Molecular Medicine Today

Volumn 4, Issue 5, 1998, Pages 221-227

  Chang, Thomas Ming Swi ^a   Prakash, Satya ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11; ENDORPHIN; GROWTH HORMONE; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR;

AMYOTROPHIC LATERAL SCLEROSIS; DWARFISM; GENETIC ENGINEERING; HEMOPHILIA B; HORMONE RELEASE; INBORN ERROR OF METABOLISM; KIDNEY FAILURE; LIVER FAILURE; MICROENCAPSULATION; PAIN; REVIEW;

ANIMALS; BIOTECHNOLOGY; CAPSULES; CELL TRANSPLANTATION; GENE THERAPY; GENETIC ENGINEERING; HUMANS; KIDNEY FAILURE; RATS;

ANIMALIA;

EID: 0031832067     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(98)01246-5     Document Type: Review

References (31)

1. Chang T.M.S. Semipermeable microcapsules. Science. 146:1964;524-525.
2. Chang T.M.S., Macintosh F.C., Mason S.G. Semipermeable aqueous microcapsules: I. Preparation and properties. Can. J. Physiol. Pharmacol. 44:1966;115-128.
3. Chang, T.M.S. (1972) Artificial Cells, Charles C. Thomas.
4. Chang, T.M.S. (1997) Artificial cells, in Encyclopedia of Human Biology (Dulbecco, R., ed.), pp. 457-463, Academic Press.
5. Chang T.M.S. Artificial cells with emphasis on bioencapsulation in biotechnology. Biotechnol. Annu. Rev. 1:1995;267-295.
6. Lanza R.P., Cooper D.K.C. Xenotransplantation of cells and tissues: application to a range of diseases, from diabetes to Alzheimer's. Mol. Med. Today. 4:1998;39-45.
7. Bangham A.D., Standish M.M., Watkin J.A. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13:1965;238-243.
8. Gregoriadis, F. (1989) Liposomes as Drug Carriers: Recent Trends and Progress, Wiley.
9. Chang, T.M.S. (1997) Blood Substitutes: Principle, Methods, Products and Clinical Trials (Vol. I), Karger.
10. Sun, A.M. (1997) Microencapsulation of cells: medical applications, in Bioartificial Organs: Science, Medicine and Technology (Ann. New York Acad. Sci. Vol. 831) (Prokop, A., Hunkeler, D. and Cherrington, A.D., eds), pp. 271-279, New York Academy of Sciences.
11. Prokop, A., Hunkeler, D. and Cherrington, A.D., eds (1997) Bioartificial Organs: Science, Medicine and Technology (Ann. New York Acad. Sci. Vol. 831), New York Academy of Sciences.
12. Basic D., Vacek I., Sun A.M. Microencapsulation and transplantation of genetically engineered cells: a new approach to somatic gene therapy. Artif. Cells Blood Substitutes Immobilization Biotechnol. 24:1996;219-255.
13. Aebischer P.et al. Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF. Hum. Gene Ther. 1:1996;851-860.
14. Saitoh Y.et al. Cell therapy with encapsulated xenogeneic tumor cells secreting β-endorphin for treatment of peripheral pain. Cell Transplant. 1(Suppl):1995;S13-S17.
15. Okada N.et al. Cytomedical therapy for IgG1 plasmacytosis in human interleukin-6 transgenic mice using hybridoma cells microencapsulated in alginate-poly(L)lysine-alginate membrane. Biochim. Biophys. Acta. 1360:1997;53-63.
16. Al-Hendy A., Hortelano G., Tannenbaum G.S., Chang P.L. Growth retardation - an unexpected outcome from growth hormone gene therapy in normal mice with microencapsulated myoblasts. Hum. Gene Ther. 7:1996;61-70.
17. Date I.et al. Chromaffin cell survival from both young and old donors is enhanced by co-grafts of polymer-encapsulated human NGF-secreting cells. NeuroReport. 7:1996;1813-1818.
18. Winn S.R.et al. Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. Proc. Natl. Acad. Sci. U. S. A. 91:1994;2324-2328.
19. Hagihara Y.et al. Transplantation of xenogeneic cells secreting β-endorphin for pain treatment: analysis of the ability of components of complement to penetrate through polymer capsules. Cell Transplant. 6:1997;527-530.
20. Coromili V., Chang T.M.S. Polydisperse dextran as a diffusing test solute to study the membrane permeability of alginate polylysine microcapsules. Biomat. Artif. Cells Immobilization Biotechnol. 21:1993;427-444.
21. Colton C.K. Implantable biohybrid artificial organs. Cell Transplant. 4:1996;415-436.
22. Dionne K.E.et al. Transport characterization of membranes for immunoisolation. Biomaterials. 17:1996;257-266.
23. Prakash S., Chang T.M.S. Growth and survival of renal failure rats that received oral microencapsulated genetically engineered E. coli DH5 cells for urea removal. Biomat. Artif. Cells Immobilization Biotechnol. 26:1998;35-51.
24. Prakash S., Chang T.M.S. Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats. Nat. Med. 2:1996;883-887.
25. Chang, T.M.S. and Prakash, S. (1996) Artificial cells and genetically engineered microencapsulated E. coli cells, for urea and ammonia removal, in Methods in Molecular Biology Vol. 62: Recombinant Gene Expression Protocols (Tuan, R., ed.), pp. 343-357, Humana Press.
26. Prakash S., Chang T.M.S. Preparation and in vitro analysis of engineered E. coli DH5 cells, microencapsulated in artificial cells for urea and ammonia removal. Biotechnol. Bioeng. 46:1995;621-626.
27. Friedman E.A. Bowel as an artificial kidney. Am. J. Kidney Dis. 28:1996;521-528.
28. Scoot B., Mulrooney H., Stuart P., Haussinger R.P. Regulation of gene expression and cellular localization of cloned K. aerogenes urease. J. Gen. Microbiol. 135:1989;1769-1776.
29. Wrong, O.M., Edmonds, C.J. and Chadwick, V.S. (1981) The Large Intestine, MTP Press.
30. Aebischer P.et al. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat. Med. 2:1996;696-699.
31. Chang, T.M.S., ed. (1998) Blood Substitutes: Principles, Methods, Products and Clinical Trials (Vol. II), Karger.